To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years
Clinical trial NCT04618640 · UNKNOWN
Trial details
- NCT number
- NCT04618640
- Sponsor
- Boryung Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-26
- Primary completion
- 2020-12-31
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.